Hostile

Quote




Anonymous said:
Enough already pls just end this, either your all in or your out.....next
Click to expand...

Shareholders can get good value by holding on a few years, or by cashing out via an enhanced Pfizer bid. It's only emotional for employees, and uk govt due to loss of major homeland company. Aside from that, fir everyone else's, it's ONLY about the Benjamins. Tick tick tick.
 




If you were an investor, what would you take?

30% premium over an inflated stock price right now?

or

Lose a shit ton of money for the next three years and then get a potential 50% return a decade from now IF all products get through Phase 3 and IF all products get approved by FDA and IF competitors don't get new/better indication and IF government doesn't get involved with prices...

Thats why Pfizer is going "hostile". They know the deal is one the shareholders will be glad to take, the board and Pascal and getting in the way at this point.
 




That's why pascal is building case against by showing shareholders the building value. He and BOD don't want them to sell out too low. He's helping them to resist low bids, and to hold out for higher. Knowledge is power. More info and confidence that shareholders have, the higher the buyout price. Consider: Pfizer wants the pipeline, so the drug projects will continue, just with different stationery.
 




Anonymous said:
That's why pascal is building case against by showing shareholders the building value. He and BOD don't want them to sell out too low. He's helping them to resist low bids, and to hold out for higher. Knowledge is power. More info and confidence that shareholders have, the higher the buyout price. Consider: Pfizer wants the pipeline, so the drug projects will continue, just with different stationery.
Click to expand...

Yeah, TOTALLY different stationery.

However, you have a point.

"The government must and will approach it from a position of even-handed neutrality and recognise that this is ultimately a matter for the shareholders of both companies," Cable told parliament."

So the UK may have left the door open.

"...In another development, AstraZeneca said it would step up its interactions with shareholders this week, following Pfizer Inc's $106 billion takeover approach, which the British drugmaker has dismissed as inadequate."

On one hand AZ is interacting with shareholders saying hold out for value, and on the other it is dismissing Pfizer's bid as inadequate.

Playing the fox?
 




Top Bottom
Back
Quote